Bone Marrow Transplantation Mortality
Mostrando 1-12 de 28 artigos, teses e dissertações.
-
1. Body composition of Fanconi anemia patients after hematopoietic stem cell transplantation
Abstract Introduction: Fanconi anemia is a rare genetic disease linked to bone marrow failure; a possible treatment is hematopoietic stem cell transplantation. Changes in the nutritional status of Fanconi anemia patients are not very well known. This study aimed to characterize body composition of adult, children and adolescent patients with Fanconi anemia
Rev. Bras. Hematol. Hemoter.. Publicado em: 2017-12
-
2. O uso de células-tronco adultas em modelos experimentais de crises convulsivas. / The use of adult stem cells in experimental models of seizures.
In Brazil, it is estimated that epilepsy affects from 2% of the population, about three million people at different ages and social classes. The use of antiepileptic drugs is the most common form of seizure control, although about 50- 70% of patients with epilepsy are refractory to medication. Because of difficulties in finding effective treatments, it is cr
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 26/05/2010
-
3. Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment
Mucopolysaccharidoses (MPS) are rare genetic diseases caused by the deficiency of one of the lysosomal enzymes involved in the glycosaminoglycan (GAG) breakdown pathway. This metabolic block leads to the accumulation of GAG in various organs and tissues of the affected patients, resulting in a multisystemic clinical picture, sometimes including cognitive imp
Genetics and Molecular Biology. Publicado em: 12/11/2010
-
4. Comparison of different severity score used in an oncologic pediatric intensive care unit / Comparação dos diferentes escores de gravidade utilizados em unidade de terapia intensiva pediátrica oncológica
Introduction: Although cancer is responsible for more deaths in children older than 1 year of age than any other disease, outcomes are improving. Improvements in survival rates and quality of life have been achieved due to early diagnosis, as well as aggressive therapies (chemotherapy, radiotherapy, surgery, bone marrow transplantation, and supportive measur
Publicado em: 2010
-
5. Indução de quimerismo hematopoetico misto com fludarabina e irradiação corporal total pre transplante de celulas progenitoras perifericas, em pacientes com neoplasias hematologicas / NST is feasible and safe for high risk hematopoietic
Background and Objectives. High mortality rate after allogeneic hematopoietic stem cell transplantation (HSCT) with myeloablative conditioning prompted us to offer HSCT with non-myeloablative conditioning (NST). Design and Methods. Between July, 2001 and October, 2005, 26 patients [acute myeloid leukemia, n=1; chronic myeloid leukemia, n=1; Hodgkin?s lymphom
Publicado em: 2006
-
6. "O transplante de medula óssea alogênico de curto período de internação" / Outpatient allogeneic bone marrow transplantation
We analyzed the results of a retrospective study of 100 patients with chronic myelogenous leukemia submitted to allogeneic stem cell transplantation in one of two settings: Group I, with 49 patients, transplanted in the traditional inpatient and group II, with 51 patients, in partial outpatient. We compared the median number of days spent in hospital, morbid
Publicado em: 2004
-
7. Avaliação clinica, histologica e imunoistoquimica de GVHDc em glandulas salivares menores
The major cause of morbidity and mortality in patients undergoing allogeneic bone marrow transplantation is graft-versus-host disease (GVHD). The clinical and histological manifestation of oral mucosa can precede other organ involvement in the GVHDc. The aim of our study was to evaluate the predictive risk factors to GVHDc, the histological and immunohistoch
Publicado em: 2003
-
8. A mucosa oral e glandulas salivares acessorias na doença do enxerto contra o hospedeiro cronica pos transplante de medula ossea : estudo prospectivo dos primeiros 63 transplantes de medula ossea : analise comparativa com parametros clinicos e biopsia de pele Hemocentro/Unicamp
Chronic graft-vs-host disease (cGVHD) is an important cause of morbity and mortality after allogeneic bone marrow transplants. Lesions ofthe oral mucosa and salivary glands are common features of cGVHD, manifesting as xerostomia, lichenoid lesions or even severe mucositis. The biopsy of specimens of the oral mucosa, collected on day +100, is commonly used as
Publicado em: 1999
-
9. Changes in plasma fibronectin during allogeneic bone marrow transplantation.
Plasma fibronectin concentrations were measured serially in nine patients undergoing allogeneic bone marrow transplantation. Concentrations were reduced by conditioning treatment and episodes of bacterial infection. Acute graft versus host disease may exacerbate or prolong this process. Reduced plasma fibronectin concentrations impair the function of the mon
-
10. A review of the current status and techniques of allogeneic bone marrow transplantation for treatment of leukaemia.
Bone marrow transplantation is now an accepted component in the overall therapy of acute and chronic (myeloid) leukaemia for some selected patients. Some of the obstacles to success have been partially overcome. Many advances in supportive care have been made. Pneumocystis carinii and herpes simplex infections are preventable. Effective decontamination of th
-
11. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation
Atherosclerosis is the major cause of adult mortality in the developed world, and a significant contributor to atherosclerotic plaque progression involves smooth muscle cell recruitment to the intima of the vessel wall. Controversy currently exists on the exact origin of these recruited cells. Here we use sex-mismatched bone marrow transplant subjects to sho
The National Academy of Sciences.
-
12. Outcome analysis of 71 clinical intestinal transplantations.
OBJECTIVE: The aim of the study was to determine risk factors associated with graft failure and mortality after transplantation of the intestine alone or as part of an organ complex. SUMMARY BACKGROUND DATA: Even with modern immunosuppressive therapies, clinical intestinal transplantation remains a difficult and unreliable procedure. Causes for this and solu